Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 11, 2025PeerJOpen Access

Development of a relapse-related RiskScore model to predict the drug sensitivity and prognosis for patients with ovarian cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

ZJZhixin JinXWXuegu WangXLXiang Li

Discussion

Loading...

Member takes

Overview

RiskScore model predicts drug sensitivity and prognosis in ovarian cancer patients, suggesting potential for personalized treatments.

Key Points

  • The RiskScore model predicts poorer outcomes for high-risk ovarian cancer patients based on five prognostic genes.
  • Key metrics from the study indicate that the high-risk group exhibits higher resistance to six identified drugs.
  • Assessment involved differential gene expression analysis using single-cell sequencing data to establish prognostic factors.
  • Finding suggests the model supports individualized treatment strategies, highlighting the importance of genetic insights in therapy.

Cite This Study

Jin et al. (2025) studied this question.

synapsesocial.com/papers/68af2695cf1dd9ea359e24d2https://doi.org/10.7717/peerj.19764
View Full Paper
Ask AI
Bookmark
Share